Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone plus capecitabine in taxane-resistant advanced breast cancer
NCT00080301Phase 3Completed
- Sponsor
- R-Pharm
- Start
- Sep 2003
- Primary completion
- Nov 2006
- Countries
- 22
01
Overview
A Phase 3 trial of ixabepilone in breast cancer, sponsored by R-Pharm. Started Sep 2003; status: completed.
02
Drugs
ixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00080301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080301.